Category: Include on Menu

The $20-per-ADS all-cash acquisition agreement follows Phase 2 progress for Divesiran and is expected to close in the first quarter of 2027, subject to shareholder, court and regulatory approvals. Key Investor Takeaways Why SLN Stock Is in Focus Silence Therapeutics (NASDAQ:SLN) has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany,…

The expanded website introduces free AI visibility assessments, paid optimization reports and healthcare provider verification initiatives as Aimwell Partners develops its professional intelligence business. Key Investor Takeaways Why AIMN Stock Is in Focus Aimwell Partners (USOTC:AIMN) has announced an expansion of its AimwellBio healthcare discovery platform, introducing additional services designed to help medical practices understand…

The all-stock transaction brings healthcare administration, technology and insurance development businesses under ECGI, although regulatory approvals remain necessary before its planned health plan can operate. Key Investor Takeaways Why ECGI Stock Is in Focus ECGI Holdings (USOTC:ECGI) has completed its acquisition of Avanta Group and its subsidiaries, establishing a foundation for a proposed integrated healthcare…

The former Ballard Power Systems executive will oversee manufacturing improvements at Plug Power’s Rochester Gigafactory as the company advances its global electrolyzer project portfolio. Key Investor Takeaways Why PLUG Stock Is in Focus Plug Power (NASDAQ:PLUG) has appointed Dr. Lee Sweetland to oversee the industrialization of its proton exchange membrane (PEM) stack technology, a key…

The $225,000 preferred-stock transaction establishes an operating platform in the Caribbean, with up to $3 million in additional consideration tied to future revenue milestones. Key Investor Takeaways Why AIBT Stock Is in Focus AIBotics (USOTC:AIBT) has completed the acquisition of operating assets associated with Jamaica-based NovaCore Labs, establishing a platform for expanding its artificial intelligence,…

Kraig Labs will address the commercial potential of genetically engineered spider silk at a November industry conference in India, providing an opportunity to engage with international silk producers and potential industry partners. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories (USOTC:KBLB) has announced that Chief Operating Officer Jon Rice will present…

NXGen Brands reports zero outstanding debt and a nearly 30% reduction in its common share count as new management prepares for a subsidiary acquisition and further corporate restructuring. Key Investor Takeaways Why NXGB Stock Is in Focus NXGen Brands (USOTC:NXGB) has announced several completed corporate restructuring measures under its ongoing Operation “Cleanup” initiative, including a…

SPYR’s first strategic transaction following its court-supervised restoration would bring a revenue-generating AI accounting business into the company, with audited financial statements and an SEC registration planned. Key Investor Takeaways Why SPYR Stock Is in Focus SPYR, Inc. (USOTC:SPYR) has entered into a binding stock purchase agreement with Certus Food LLC, operating as Ledjr AI,…